Holen Sie sich die Stockscreener-App
0.81
2.41%
-0.02
Handel nachbörslich:
.81
Schlusskurs vom Vortag:
$0.83
Offen:
$0.8102
24-Stunden-Volumen:
15,309
Relative Volume:
0.14
Marktkapitalisierung:
$4.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-736.70K
KGV:
-81.00
EPS:
-0.01
Netto-Cashflow:
$-4.14M
1W Leistung:
-2.40%
1M Leistung:
+8.87%
6M Leistung:
-21.74%
1J Leistung:
-65.97%
1-Tages-Spanne:
$0.8005
$0.85
1-Wochen-Bereich:
$0.767
$0.85
52-Wochen-Spanne:
$0.6608
$2.59
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Firmenname
Xortx Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.81 | 4.27M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Xortx Therapeutics Inc Aktie (XRTX) Neueste Nachrichten
How to monitor XORTX Therapeutics Inc. with trend dashboards2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser
XORTX Therapeutics to Host Investor Webinar on Strategic Developments - TipRanks
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10 - GlobeNewswire
$700M Annual Market: XORTX Therapeutics Advancing Late-Stage Gout Drug XORLO Toward 2026 FDA Filing - Stock Titan
Tools to monitor XORTX Therapeutics Inc. recovery probability2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Reversal indicators forming on XORTX Therapeutics Inc. stockJuly 2025 Institutional & Growth Focused Entry Reports - Newser
Does XORTX Therapeutics Inc. fit your quant trading modelMarket Trend Report & Free Real-Time Volume Trigger Notifications - Newser
Combining machine learning predictions for XORTX Therapeutics Inc.Market Performance Summary & Weekly Breakout Stock Alerts - Newser
Regression analysis insights on XORTX Therapeutics Inc. performanceBond Market & Fast Entry and Exit Trade Plans - Newser
Can XORTX Therapeutics Inc. expand into new marketsDividend Hike & Verified Chart Pattern Trade Signals - khodrobank.com
Is this a good reentry point in XORTX Therapeutics Inc.2025 Major Catalysts & Verified High Yield Trade Plans - Newser
XORTX Advances Gout Treatment Program with IND Preparation - TipRanks
XORTX's Path to NDA Filing for XORLO™: A Strategic Milestone in Gout Therapy Innovation - AInvest
Visual trend scoring systems applied to XORTX Therapeutics Inc.Insider Selling & Real-Time Price Movement Reports - Newser
Major FDA Filing Milestone: XORTX's Novel Gout Treatment XORLO Advances Toward Clinical Trials - Stock Titan
Real time scanner hits for XORTX Therapeutics Inc. explainedEarnings Growth Summary & Stepwise Swing Trade Plans - Newser
Will XORTX Therapeutics Inc. stock go up soon2025 Trade Ideas & High Win Rate Trade Tips - Newser
Is XORTX Therapeutics Inc. stock a good dividend stockJuly 2025 Macro Moves & Consistent Return Investment Signals - khodrobank.com
Will XORTX Therapeutics Inc. outperform during market ralliesQuarterly Risk Review & Low Risk Profit Maximizing Plans - khodrobank.com
Using data models to predict XORTX Therapeutics Inc. stock movement2025 Support & Resistance & Growth Focused Investment Plans - Newser
Is XORTX Therapeutics Inc. gaining market shareJuly 2025 Sentiment & High Conviction Investment Ideas - khodrobank.com
Using Ichimoku Cloud for XORTX Therapeutics Inc. technicalsWeekly Trade Recap & Fast Gain Swing Alerts - Newser
Is XORTX Therapeutics Inc. attractive for institutional investors2025 Valuation Update & Consistent Growth Stock Picks - khodrobank.com
Can XORTX Therapeutics Inc. expand its profit marginsEarnings Risk Report & Daily Profit Focused Stock Screening - khodrobank.com
What are XORTX Therapeutics Inc.’s recent SEC filings showingMarket Sentiment Summary & Daily Risk Controlled Trade Plans - khodrobank.com
Live market analysis of XORTX Therapeutics Inc.2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs - MSN
What are XORTX Therapeutics Inc.’s earnings expectations2025 Trade Ideas & Safe Entry Zone Tips - khodrobank.com
Best data tools to analyze XORTX Therapeutics Inc. stockWeekly Risk Report & Risk Controlled Daily Plans - Newser
Trade Report: Can XORTX Therapeutics Inc. expand its profit marginsPortfolio Update Summary & Low Risk Growth Stock Ideas - khodrobank.com
Institutional scanner results for XORTX Therapeutics Inc.Fed Meeting & AI Powered Buy and Sell Recommendations - Newser
Using R and stats models for XORTX Therapeutics Inc. forecastingProduct Launch & Short-Term Trading Opportunity Alerts - Newser
Is XORTX Therapeutics Inc. still worth holding after the dip2025 Winners & Losers & Low Risk Investment Opportunities - Newser
XORTX Therapeutics Inc. stock daily chart insightsDollar Strength & Weekly Top Performers Watchlists - Newser
How to use a screener to detect XORTX Therapeutics Inc. breakoutsSwing Trade & Expert Curated Trade Setups - Newser
What indicators show strength in XORTX Therapeutics Inc.Weekly Market Report & Safe Capital Growth Tips - Newser
Is XORTX Therapeutics Inc. stock good for income investorsForecast Cut & AI Enhanced Trading Signals - 한국정경신문
Is XORTX Therapeutics Inc. likely to announce a buyback2025 Fundamental Recap & Low Risk Entry Point Guides - 한국정경신문
Is XORTX Therapeutics Inc. attractive for institutional investors getLinesFromResByArray error: size == 0 - sisain.net
Visual analytics tools that track XORTX Therapeutics Inc. performanceWeekly Loss Report & Real-Time Volume Analysis - Newser
Will XORTX Therapeutics Inc. continue its uptrendWeekly Profit Report & AI Based Buy and Sell Signals - Newser
Finanzdaten der Xortx Therapeutics Inc-Aktie (XRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):